Undeclared APIs In ED Supplements From China Prompt FDA Warning
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The U.S. FDA warned consumers Dec. 28 about using erectile dysfunction dietary supplements produced in China because some products contained undeclared active pharmaceutical ingredients
You may also be interested in...
Singapore's S*BIO Moving JAK2 Inhibitor Into Phase II In Early 2010
S*BIO's collaboration with Onyx for two JAK2 inhibitors was one of the biggest biotech deals in Asia; data on one compound presented at ASH.
Singapore's S*BIO Moving JAK2 Inhibitor Into Phase II In Early 2010
S*BIO's collaboration with Onyx for two JAK2 inhibitors was one of the biggest biotech deals in Asia; data on one compound presented at ASH.
On To Phase II Trials For JAK2, Singapore's S*BIO Reports
PERTH, Australia - Singapore-based biotech S*BIO reported positive data on its Phase I trials for its Janus kinase 2 inhibitor SB1518 at the American Society of Hematology annual meeting in New Orleans Dec. 7